Atlas Trials

GS1-144 in Participants With Hepatic Impairment and Healthy Female

Clinical trial NCT07491289 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07491289
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment and Healthy Female
Start date
2026-04-20
Primary completion
2027-01-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.